ADAP Waiting List Update: 88 People in 6 States as of September 13
September 14, 2012
As of September 13, 2012, there are 88 individuals on ADAP waiting lists in six states. With the recent receipt of the $75 million in ADAP Emergency Relief Funding (ERF), Georgia, North Carolina and Virginia no longer have individuals on their waiting lists. However, Louisiana added 24 individuals and South Dakota added one individual to the wait lists. Florida's number of individuals on their waiting list remained steady. To see a list of states with access restrictions please visit NASTAD's website.
Moving forward, due to the significant decrease in the number of individuals on waiting lists, the ADAP Watch will be released monthly on the second Friday of each month. NASTAD is committed to monitoring developments in access restrictions to ADAPs and will increase the frequency of reporting on waiting lists if the situation warrants.
ADAP enrollment is not static and ADAPs continue to experience increased strain on their programs due to new enrollment of individuals based on increased efforts to identify new individuals living with HIV or re-engagement of individuals lost to care as part the National HIV/AIDS Strategy. Even with the recent receipt of ERFs, some states were unable to close their waiting lists entirely, and two states may implement new cost containment measures or waiting lists by the end of this FY2012.
House and Senate leaders have agreed to a six month Continuing Resolution (CR) that will fund the government through March 2013 at the Budget Control Act level, which will result in approximately flat-funding at FY2012 levels. The House passed the CR yesterday and the Senate is expected to vote on this measure next week.
In an effort to streamline and assist clients in need of medications, The Common Patient Assistance Program Application (CPAPA) was launched on September 12 and is now available on the NASTAD website or at http://hab.hrsa.gov/patientassistance/index.html. This single common application allows uninsured individuals living with HIV and/or their providers/caregivers to use one application to apply for multiple patient assistance programs (PAPs) that together provide an entire course of antiretroviral therapy. To see additional information on pharmaceutical company co-payment assistance and patient assistance programs, please visit the Positively Aware website or the Fair Pricing Coalition's website.
This article was provided by National Alliance of State and Territorial AIDS Directors. Visit NASTAD's website to find out more about their activities and publications.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)